tofogliflozin
Showing 1 - 3 of 3
T2DM (Type 2 Diabetes), Metformin, SGLT2-Inhibitors Trial in Matsumoto (Tofogliflozin, Metformin)
Recruiting
- T2DM (Type 2 Diabetes Mellitus)
- +2 more
- Tofogliflozin
- Metformin
-
Matsumoto, Nagano, JapanShinshu University
Jul 21, 2022
Type 2 Diabetes Trial in Japan (Tofogliflozin, GLP-1 analogue)
Completed
- Type 2 Diabetes Mellitus
- Tofogliflozin
- GLP-1 analogue
-
Atsuta-ku, Aichi, Japan
- +10 more
Nov 15, 2020
Non-alcoholic Fatty Liver Disease Trial in Kanazawa (Tofogliflozin, Glimepiride)
Completed
- Non-alcoholic Fatty Liver Disease
- Tofogliflozin
- Glimepiride
-
Kanazawa, Ishikawa, JapanKanazawa University Graduate School of Medical Sciences
Jun 30, 2021